A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Fatty Acid Panel, Mitochondrial (C8-C18), Serum
Test Code94823
CPT Codes
82542
Includes
Octanoic, C8:0
Decenoic, C10:1
Decanoic, C10:0
Lauroleic, C12:1
Lauric, C12:0
Tetradecadienoic, C14:2
Myristoleic, C14:1
Myristic, C14:0
Hexadecadienoic, C16:2
Palmitoleic, C16:1w7
Palmitic, C16:0
Linoleic, C18:2w6
Oleic, C18:1w9
Stearic, C18:0
Interpretation
Decenoic, C10:1
Decanoic, C10:0
Lauroleic, C12:1
Lauric, C12:0
Tetradecadienoic, C14:2
Myristoleic, C14:1
Myristic, C14:0
Hexadecadienoic, C16:2
Palmitoleic, C16:1w7
Palmitic, C16:0
Linoleic, C18:2w6
Oleic, C18:1w9
Stearic, C18:0
Interpretation
Preferred Specimen
1 mL serum collected in red-top tube (no gel)
Patient Preparation
Fasting required (overnight fast). No alcohol consumption for 24 hours prior to draw.
For pediatric patients, fasting is not required, but sample collection should occur prior to the next meal or scheduled feeding.
Minimum Volume
0.2 mL
Other Acceptable Specimens
Plasma collected in an EDTA (lavender-top) tube
Instructions
Patient age and gender are required for reporting
Transport Temperature
Frozen
Specimen Stability
Room temperature: Unacceptable
Refrigerated: 7 days
Frozen: 28 days
Refrigerated: 7 days
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis • Lipemia • Non-fasting specimens • Serum separator tube (SST)
Methodology
Gas Chromatography/Tandem Mass Spectrometer
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 3 days a week.
Clinical Significance
Mitochondrial Fatty Acids (C8-C18), to be used to evaluate patients for certain mitochondrial fatty acid oxidation defects as well as for monitoring of dietary therapy.